Corvus Pharmaceuticals Inc (CRVS)
5.00
-0.09
(-1.77%)
USD |
NASDAQ |
Dec 20, 16:00
5.00
0.00 (0.00%)
After-Hours: 20:00
Corvus Pharmaceuticals Total Liabilities (Quarterly): 46.41M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 62.68M |
| Sarepta Therapeutics Inc | 2.379B |
| Cara Therapeutics Inc | 50.62M |
| Atara Biotherapeutics Inc | 233.24M |
| Clearside Biomedical Inc | 63.95M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 58.82M |
| Shareholders Equity (Quarterly) | 12.41M |